A Chinese hospital says Alibaba's PANDA AI tool has analyzed 180,000 CT scans and detected ~24 pancreatic cancer cases since its deployment in November 2024
A tool for spotting pancreatic cancer in routine CT scans has had promising results, one example of how China is racing to apply A.I. to medicine's tough problems.
The hospital can apply a pancreatic-cancer detection layer across a large existing CT volume, potentially flagging cases for clinical follow-up that might otherwise receive less attention.
Alibaba gains a real-world hospital deployment and a reported operating record for PANDA; the hospital’s claims will need clinical validation beyond the reported detections.
Second-order effects
Radiology departments and AI vendors face greater pressure to show that detection tools improve review workflows and follow-up decisions, not merely process high scan volumes.
Broader use of routine imaging data raises the importance of privacy, security, and accountability practices alongside the technical performance of the model.
Third-order effects
If opportunistic CT analysis proves clinically reliable across sites, medical imaging could shift toward routine scans serving as continuous screening inputs rather than single-purpose diagnostic records.
The competitive advantage in clinical AI may increasingly depend on access to deployed hospital workflows, representative data, and evidence-generation capacity—not just model development.
The trend: This is one data point in the industrialization of clinical AI: embedding specialized detection models into high-volume care workflows and testing their value through deployment.
China's edge isn't just data volume; it's willingness to deploy imperfect systems in the real world and iterate in production. This is the kind of AI story that actually matters. Not chatbots. Not demos. Not benchmarks. A hospital in China used AI to scan routine CT images and
A.I. detecting early pancreatic cancer in China, based on @NatureMedicine validation publication “I think you can 100% say AI saved their lives.” gift link https://www.nytimes.com/... [image]
This is one of the most compelling real-world use cases of AI I've seen yet: “Several of their CT scans had raised no alarms until they were flagged by the A.I. tool. ‘I think you can 100 percent say A.I. saved their lives,’ he said."https://www.nytimes.com/ ...
“The tool has since analyzed more than 180,000 abdominal or chest CTs, helping doctors detect about two dozen cases of pancreatic cancer, 14 of which were in the early stage....”
AI model PANDA spots early pancreatic cancer on routine non-contrast CT (abdomen or chest), often outperforming experienced radiologists even for small, early-stage tumors, and could enable large-scale, low-cost opportunistic screening without changing current CT workflows. [imag…
This same team of researchers, which includes AI researchers with Alibaba who developed the PANDA tool, published an article demonstrating this system's usefulness in Nature Medicine in 2023. https://www.nature.com/...
In China, A.I. Is Finding Deadly Tumors That Doctors Might Miss—A tool for spotting pancreatic cancer in routine CT scans has had promising results, one example of how China is racing to apply A.I. to medicine's tough problems. @vwang3 https://www.nytimes.com/...
“The tool is one example of how Chinese tech companies & hospitals are racing to apply A.I. to some of medicine's most stubborn problems.” https://www.nytimes.com/...
Classic AI article - the AI correctly identifies 93% of pancreatic cancer cases but questioned by “experts” since there may be some false positives, with no discussion of human doctor false positive/negative comparison
The PANDA (#PancreaticCancer detection using #AI) study published in @NatureMedicine two years ago got written up this morning in the @nytimes (Subscription required) https://www.nytimes.com/...